Weight loss tablets or injections: the real differences

The myth that tablets are always easier, and why the answer is more nuanced

The assumption most people arrive with is straightforward: tablets beat injections for convenience. Swallowing a pill every morning sounds simpler than a weekly self-injection. That logic is understandable, but it reverses quickly once you look at the practicalities.

The Wegovy tablet has a strict morning routine. It must be taken first thing on an empty stomach with a small sip of plain water (roughly 120ml) and you then need to wait at least 30 minutes before eating, drinking anything else (including coffee), or taking other oral medicines. Miss that window and you lose most of the dose's absorption. The injection, by contrast, goes in once a week at any time of day that suits you, with no food or drink restrictions around it.

Neither is objectively easier. For someone whose mornings are already structured, the tablet fits naturally. For someone whose schedule is unpredictable before noon, a once-weekly injection can actually be the lower-effort option. The NHS patient-level guidance on tirzepatide and on semaglutide sets out the practical requirements for each format in detail, worth reading before you form a strong preference either way.

One quick check worth doing before your consultation: look at your typical weekday morning and count how often you eat or drink something within 30 minutes of waking. That single habit tells you a lot about how the tablet routine would fit your life.

What the trial data says about results, and where the comparisons get tricky

Results from weight loss injections and the newer tablet have been studied in separate clinical programmes, which makes side-by-side comparison harder than headlines suggest.

The SURMOUNT-1 trial of tirzepatide (Mounjaro, weekly injection) reported average body-weight reductions of around 20–21% at the highest 15mg dose over 72 weeks, in thousands of adults with obesity. The STEP 1 trial of semaglutide 2.4mg (Wegovy injection, 68 weeks) found an average reduction of around 15%. For the newer Wegovy tablet, the OASIS 4 phase-3 trial (64 weeks, 307 adults) found an average weight loss of around 13.6% at the 25mg maintenance dose; among participants who stuck fully to the regimen throughout, that figure was closer to 17%.

Those percentages come from trials with different lengths, different populations and different starting doses, they are not a clean ranking. What they do confirm is that all three options produce meaningful, clinically significant weight loss when combined with lifestyle changes, and that the scale of effect differs. The NICE appraisal of tirzepatide (TA1026) and its appraisal of semaglutide injection (TA875) both reflect on the evidence base in depth if you want to go further.

If you are wondering whether weight loss tablets are as good as injections, that dedicated guide works through the numbers carefully.

Side effects, eligibility and what actually drives the prescriber's decision

Both injection and tablet formats share a broadly similar side-effect profile: nausea, digestive discomfort, changes in appetite and, for some people, fatigue or headaches, particularly after starting or stepping up. These effects are most noticeable early on and usually settle. The oral format showed a higher rate of gastrointestinal effects in its trial (around 74% of participants reported them, compared with 42% on placebo) though most were mild to moderate and transient.

Eligibility criteria also differ slightly by product. Mounjaro injection is licensed for adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition. The Wegovy injection shares a similar threshold. The Wegovy tablet carries the same licensed BMI thresholds. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. BMI alone never settles the question, the prescriber reviews your full health picture, any medicines you already take, and which format is realistically manageable for you.

You can read about the full range of licensed weight loss injection options and what distinguishes them, or explore the weight loss treatments overview to see everything currently dispensed. For questions about cost, pricing for weight loss injections covers what private treatment typically involves. If you are leaning toward the tablet specifically, choosing tablets instead of injections goes into practical detail on making that switch.

The decision between whether tablets or injections are better for weight loss is, in the end, a clinical one, and it is made by a prescriber who knows your situation. That conversation is where it should start.